hodgkins lymphoma

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Hodgkins Lymphoma, Non Hodgkins Lymphoma Trial in Houston (TAA-specific CTLs)

Recruiting
  • Hodgkins Lymphoma
  • Non Hodgkins Lymphoma
  • TAA-specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Jul 14, 2022

Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,

Terminated
  • Double Cord Blood Transplant
  • +8 more
  • TXA127 300 mcg/kg/day
  • TXA127 1000 mcg/kg/day
  • Houston, Texas
    MD Anderson Cancer Center
Dec 7, 2020

Hodgkins Lymphoma Trial in Cologne (Rituximab, BEACOPP escalated)

Completed
  • Hodgkins Lymphoma
  • Cologne, Germany
    1st Dept. of Medicine, Cologne University Hospital
Nov 11, 2020

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Hodgkins Lymphoma Trial in Italy, United Kingdom, United States (Avelumab)

Terminated
  • Hodgkins Lymphoma
  • Duarte, California
  • +12 more
Apr 3, 2020

Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen

Terminated
  • Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic

Terminated
  • Chronic Myelogenous Leukemia
  • +4 more
  • Allogeneic stem cell transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2018

Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Lymphoproliferative Disorder Trial in Washington, Valhalla (EBV CTL's, Peripheral

Completed
  • Non-Hodgkins Lymphoma
  • +2 more
  • EBV CTL's
  • Peripheral Blood Donor
  • Washington, District of Columbia
  • +1 more
Dec 20, 2017

Non-hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma Trial in Hershey (Oncaspar, Doxil, Decadron)

Terminated
  • Non-hodgkins Lymphoma
  • +2 more
  • Oncaspar, Doxil, Decadron
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 23, 2017

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS) Trial in Kansas City (Administration of

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Administration of hyperbaric oxygen
  • Kansas City, Kansas
    University of Kansas Medical Center
May 9, 2017

Hodgkins Lymphoma Trial (8 cycles BEACOPPesc plus oral contraceptive, 8 cycles BEACOPPesc plus Goserelin)

Completed
  • Hodgkins Lymphoma
  • 8 cycles BEACOPPesc plus oral contraceptive
  • 8 cycles BEACOPPesc plus Goserelin
  • (no location specified)
Jun 22, 2012

Hodgkins Lymphoma, Non-Hodgkin Lymphoma Trial in Houston (LMP1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES, LMP2-SPECIFIC CYTOTOXIC

Terminated
  • Hodgkins Lymphoma
  • Non-Hodgkin Lymphoma
  • LMP1 SPECIFIC CYTOTOXIC T-LYMPHOCYTES
  • LMP2-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
  • Houston, Texas
  • +1 more
May 22, 2012

Brown Fat Activity and White Fat Accumulation

Completed
  • Hodgkins Lymphoma
  • Non-hodgkins Lymphoma
    • Los Angeles, California
      Children's Hospital Los Angeles
    Jan 24, 2012